117 related articles for article (PubMed ID: 1876020)
1. Characterization of aminoalkylindole binding: selective displacement by cannabinoids.
Haycock DA; Kuster JE; Stevenson JI; Ward SJ; D'Ambra T
NIDA Res Monogr; 1990; 105():304-5. PubMed ID: 1876020
[No Abstract] [Full Text] [Related]
2. Aminoalkylindoles (AAIs): a new route to the cannabinoid receptor?
Ward SJ; Baizman E; Bell M; Childers S; D'Ambra T; Eissenstat M; Estep K; Haycock D; Howlett A; Luttinger D
NIDA Res Monogr; 1990; 105():425-6. PubMed ID: 1908557
[No Abstract] [Full Text] [Related]
3. Putative aminoalkylindoles (AAI) antagonists.
Casiano FM; Arnold R; Haycock D; Kuster J; Ward SJ
NIDA Res Monogr; 1990; 105():295-6. PubMed ID: 1876017
[No Abstract] [Full Text] [Related]
4. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
Kuster JE; Stevenson JI; Ward SJ; D'Ambra TE; Haycock DA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1352-63. PubMed ID: 8450470
[TBL] [Abstract][Full Text] [Related]
5. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
Reggio PH; Basu-Dutt S; Barnett-Norris J; Castro MT; Hurst DP; Seltzman HH; Roche MJ; Gilliam AF; Thomas BF; Stevenson LA; Pertwee RG; Abood ME
J Med Chem; 1998 Dec; 41(26):5177-87. PubMed ID: 9857088
[TBL] [Abstract][Full Text] [Related]
6. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics.
Eissenstat MA; Bell MR; D'Ambra TE; Alexander EJ; Daum SJ; Ackerman JH; Gruett MD; Kumar V; Estep KG; Olefirowicz EM
J Med Chem; 1995 Aug; 38(16):3094-105. PubMed ID: 7636873
[TBL] [Abstract][Full Text] [Related]
7. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.
Aung MM; Griffin G; Huffman JW; Wu M; Keel C; Yang B; Showalter VM; Abood ME; Martin BR
Drug Alcohol Depend; 2000 Aug; 60(2):133-40. PubMed ID: 10940540
[TBL] [Abstract][Full Text] [Related]
8. AM630, a competitive cannabinoid receptor antagonist.
Pertwee R; Griffin G; Fernando S; Li X; Hill A; Makriyannis A
Life Sci; 1995; 56(23-24):1949-55. PubMed ID: 7776818
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A.
Petitet F; Marin L; Doble A
Neuroreport; 1996 Feb; 7(3):789-92. PubMed ID: 8733746
[TBL] [Abstract][Full Text] [Related]
10. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
Stark S; Pacheco MA; Childers SR
Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
[TBL] [Abstract][Full Text] [Related]
11. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles.
Jansen EM; Haycock DA; Ward SJ; Seybold VS
Brain Res; 1992 Mar; 575(1):93-102. PubMed ID: 1504787
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
Shim JY; Collantes ER; Welsh WJ; Subramaniam B; Howlett AC; Eissenstat MA; Ward SJ
J Med Chem; 1998 Nov; 41(23):4521-32. PubMed ID: 9804691
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.
Devlin MG; Christopoulos A
J Neurochem; 2002 Mar; 80(6):1095-102. PubMed ID: 11953460
[TBL] [Abstract][Full Text] [Related]
14. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.
Houston DB; Howlett AC
Cell Signal; 1998 Oct; 10(9):667-74. PubMed ID: 9794249
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.
Katoch-Rouse R; Pavlova OA; Caulder T; Hoffman AF; Mukhin AG; Horti AG
J Med Chem; 2003 Feb; 46(4):642-5. PubMed ID: 12570386
[TBL] [Abstract][Full Text] [Related]
16. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats.
Berrendero F; Romero J; García-Gil L; Suarez I; De la Cruz P; Ramos JA; Fernández-Ruiz JJ
Biochim Biophys Acta; 1998 Sep; 1407(3):205-14. PubMed ID: 9748581
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Ross RA; Brockie HC; Fernando SR; Saha B; Razdan RK; Pertwee RG
Br J Pharmacol; 1998 Nov; 125(6):1345-51. PubMed ID: 9863666
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid-like effects of aminoalkylindole compounds on the physical properties of brain membranes: fluorescence polarization studies.
Moldovan JC; Ward SJ; Bloom AS
NIDA Res Monogr; 1990; 105():302-3. PubMed ID: 1876019
[No Abstract] [Full Text] [Related]
19. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
Pertwee RG; Thomas A; Stevenson LA; Ross RA; Varvel SA; Lichtman AH; Martin BR; Razdan RK
Br J Pharmacol; 2007 Mar; 150(5):586-94. PubMed ID: 17245367
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand.
Lan R; Gatley J; Lu Q; Fan P; Fernando SR; Volkow ND; Pertwee R; Makriyannis A
AAPS PharmSci; 1999; 1(2):E4. PubMed ID: 11741201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
